GC Cell (XKRX:144510) Accounts Payable & Accrued Expense : ₩7,427 Mil (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is GC Cell Accounts Payable & Accrued Expense?

GC Cell's quarterly accounts payable & accrued expense increased from Sep. 2023 (₩5,476 Mil) to Dec. 2023 (₩6,095 Mil) and increased from Dec. 2023 (₩6,095 Mil) to Mar. 2024 (₩7,427 Mil).

GC Cell's annual accounts payable & accrued expense declined from Dec. 2021 (₩19,921 Mil) to Dec. 2022 (₩15,946 Mil) and declined from Dec. 2022 (₩15,946 Mil) to Dec. 2023 (₩6,095 Mil).

GC Cell Accounts Payable & Accrued Expense Historical Data

The historical data trend for GC Cell's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GC Cell Accounts Payable & Accrued Expense Chart

GC Cell Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

4,406.42

4,643.31

19,921.32

15,946.15

6,095.40

GC Cell Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															9,910.24	6,231.55	5,476.03	6,095.40	7,426.87

GC Cell Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

GC Cell (XKRX:144510) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » GC Cell Corp (XKRX:144510) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

30 beongil to giheung-gu, Gyeonggi, 107 Lee Hyun, Yongin, KOR, 16 924

Website

https://www.gccell.com

GC Cell Corp engages in the provision of anti-cancer immunotherapy. The company is developing an anticancer drug, which is in Phase II clinical trials; and stem cell treatment drugs. It also provides cell banking, sample inspection, clinical trial, and bio logistics services.

GC Cell (XKRX:144510) Headlines

No Headlines